UNITEDHEALTH GROUP INCORPORATED (NYSE:UNH) Files An 8-K Regulation FD DisclosureItem 7.01.
Regulation FD Disclosure.
Senior business leaders of UnitedHealth Group Incorporated (the “Company”) will discuss areas the Company has targeted for future growth and engage in a question and answer session at the Morgan Stanley 15th Annual Global Healthcare Conference in New York, New York on Tuesday, September 12, 2017 beginning at 11:45 a.m., Eastern Time.
A live audio webcast of the presentation will be made available through the Investors page of the Company’s website at www.unitedhealthgroup.com.
The information in this Item 7.01 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing.
About UNITEDHEALTH GROUP INCORPORATED (NYSE:UNH)
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum. UnitedHealthcare provides healthcare benefits to a range of customers and markets through its UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement, UnitedHealthcare Community & State, and UnitedHealthcare Global businesses. Optum is a health services business serving the healthcare marketplace, including payers, care providers, employers, governments, life sciences companies and consumers, through its OptumHealth, OptumInsight and OptumRx businesses. UNITEDHEALTH GROUP INCORPORATED (NYSE:UNH) Recent Trading Information
UNITEDHEALTH GROUP INCORPORATED (NYSE:UNH) closed its last trading session down -0.42 at 197.75 with 2,205,962 shares trading hands.
